Skip to main content

Relative contribution of preload and afterload to the reduction in cardiac output caused by nitric oxide synthase inhibition with L-N(G)-methylarginine hydrochloride 546C88.

Publication ,  Journal Article
Harrison, RW; Thakkar, RN; Senzaki, H; Ekelund, UE; Cho, E; Kass, DA; Hare, JM
Published in: Crit Care Med
May 2000

OBJECTIVE: The nitric oxide synthase inhibitor L-N(G)-methylarginine hydrochloride (L-NMMA HC1 546C88) causes reductions in cardiac output (CO), a potential limitation to clinical application. This drop in CO exceeds that from phenylephrine at matched systemic arterial pressure. We tested the hypothesis that the greater fall in CO attributable to L-NMMA primarily reflects a difference in venoconstriction between agents, such that phenylephrine produces larger increases in preload (an independent determinant of CO). DESIGN: Random infusion of phenylephrine or L-NMMA. SETTING: An animal research laboratory. SUBJECTS: Eight healthy, conscious, male dogs. INTERVENTIONS: L-N(G)-methylarginine hydrochloride (20 mg/kg for 1 hr) and phenylephrine (0.5 to 3 microg/kg/min) were administered into eight dogs chronically instrumented to measure left ventricular pressure and dimension. Data were measured at a constant heart rate (140 beats/min) to render CO proportional to stroke dimension. MEASUREMENTS AND MAIN RESULTS: At a matched increase in afterload (effective arterial elastance), L-NMMA increased preload (end-diastolic dimension) to a lesser degree (3.8%+/-1.5%, p < .05) than phenylephrine (9.6%+/-1.6%, p < .05 vs. L-NMMA). Neither L-NMMA nor phenylephrine affected the slope of the end-systolic pressure dimension relationship, although L-NMMA shifted the relationship rightward (1.7+/-0.7 mm, p < .05), consistent with a mild negative inotropic effect. L-NMMA decreased the stroke dimension to a greater extent than phenylephrine (-24.1%+/-6.8% and -10.6%+/-3.4%, respectively, p < .05). CONCLUSIONS: Differential CO responses to phenylephrine and L-NMMA were primarily attributable to changes in preload. Variable venular vs. arteriolar constrictor effects must be considered when evaluating the integrated cardiovascular response to a vasoactive agent.

Duke Scholars

Published In

Crit Care Med

DOI

ISSN

0090-3493

Publication Date

May 2000

Volume

28

Issue

5

Start / End Page

1263 / 1268

Location

United States

Related Subject Headings

  • omega-N-Methylarginine
  • Ventricular Function, Left
  • Vasoconstrictor Agents
  • Vascular Resistance
  • Shock, Septic
  • Phenylephrine
  • Nitric Oxide Synthase
  • Male
  • Humans
  • Enzyme Inhibitors
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Harrison, R. W., Thakkar, R. N., Senzaki, H., Ekelund, U. E., Cho, E., Kass, D. A., & Hare, J. M. (2000). Relative contribution of preload and afterload to the reduction in cardiac output caused by nitric oxide synthase inhibition with L-N(G)-methylarginine hydrochloride 546C88. Crit Care Med, 28(5), 1263–1268. https://doi.org/10.1097/00003246-200005000-00001
Harrison, R. W., R. N. Thakkar, H. Senzaki, U. E. Ekelund, E. Cho, D. A. Kass, and J. M. Hare. “Relative contribution of preload and afterload to the reduction in cardiac output caused by nitric oxide synthase inhibition with L-N(G)-methylarginine hydrochloride 546C88.Crit Care Med 28, no. 5 (May 2000): 1263–68. https://doi.org/10.1097/00003246-200005000-00001.
Harrison, R. W., et al. “Relative contribution of preload and afterload to the reduction in cardiac output caused by nitric oxide synthase inhibition with L-N(G)-methylarginine hydrochloride 546C88.Crit Care Med, vol. 28, no. 5, May 2000, pp. 1263–68. Pubmed, doi:10.1097/00003246-200005000-00001.
Harrison RW, Thakkar RN, Senzaki H, Ekelund UE, Cho E, Kass DA, Hare JM. Relative contribution of preload and afterload to the reduction in cardiac output caused by nitric oxide synthase inhibition with L-N(G)-methylarginine hydrochloride 546C88. Crit Care Med. 2000 May;28(5):1263–1268.

Published In

Crit Care Med

DOI

ISSN

0090-3493

Publication Date

May 2000

Volume

28

Issue

5

Start / End Page

1263 / 1268

Location

United States

Related Subject Headings

  • omega-N-Methylarginine
  • Ventricular Function, Left
  • Vasoconstrictor Agents
  • Vascular Resistance
  • Shock, Septic
  • Phenylephrine
  • Nitric Oxide Synthase
  • Male
  • Humans
  • Enzyme Inhibitors